What GMP ISO 22716 Certification Actually Means — and Why It Should Be Non-Negotiable When Choosing a Skincare Manufacturer

If you're building a skincare brand, launching a product line for your med spa, or developing physician-branded clinical treatments, you've probably encountered the phrase "GMP certified" in manufacturer marketing. What you may not know is what that phrase actually means — and more importantly, what it doesn't mean when a manufacturer uses it loosely.

GMP, Good Manufacturing Practice, is a category with meaningful variation. The specific standard that matters in professional and clinical skincare manufacturing is GMP ISO 22716 — the internationally recognized cosmetic Good Manufacturing Practice standard. Not all manufacturers claiming GMP compliance operate to this standard, and the difference matters for the safety, consistency, and regulatory standing of every product your brand puts its name on.

Trilogy Laboratories in Fort Myers, Florida is a GMP ISO 22716-certified and MoCRA-compliant private label and custom skincare manufacturer serving beauty brands, brand creators, licensed estheticians, dermatologists, plastic surgeons, and medical spas. Founded by Dr. Kristen Flaharty, PharmD — a pharmaceutical scientist with more than 20 years of drug product development experience — the quality standard at Trilogy was established from day one with the rigor Dr. Flaharty applied throughout her pharmaceutical career. This blog is for the brand owners, practitioners, and brand creators who want to understand what they're actually buying when a manufacturer claims certification — and why it changes everything about what ends up in the bottle.

What ISO 22716 Actually Requires

ISO 22716 is a global standard developed by the International Organization for Standardization specifically for the manufacture of cosmetic products. It establishes requirements across every phase of production, from raw material receiving and storage through manufacturing, filling, packaging, and distribution. The key operational requirements include:

• Documented procedures for every production step: Everything that happens in the facility — raw material testing, equipment cleaning, batch production, quality checks — must be documented in standardized written procedures and executed consistently.
• Traceability: Every batch of every product must be traceable from raw material intake to finished product shipment. If a question arises about ingredient quality or product performance, the manufacturer can trace exactly what went into each batch and when.
• Contamination controls: Physical, chemical, and microbiological contamination risks are actively managed through facility design, equipment validation, personnel protocols, and environmental monitoring.
• Quality control and testing: Raw materials are tested on intake. In-process testing monitors production at critical points. Finished products are tested against defined specifications before release. A product that doesn't pass specification doesn't ship.
• Regulatory compliance: ISO 22716 certification requires that all manufacturing operations meet the regulatory requirements of the markets where products will be sold. In the United States, this includes compliance with the FDA's Modernization of Cosmetics Regulation Act (MoCRA) — the most significant update to federal cosmetics law in decades.

Trilogy's FDA-registered manufacturing facility was purpose-designed and built specifically for pharmaceutical-grade manufacturing standards. The facility, the documentation, and the operational protocols were built by a pharmacist to the standards she applied to prescription drug products — not adapted from less rigorous practices as the company grew.

Why the Person Who Founded the Company Matters for Quality

The standard a manufacturer operates to is a reflection of the standard the people who built it apply to their own work. Dr. Flaharty's background isn't incidental to Trilogy's quality position — it's the origin of it.

In pharmaceutical drug product development, active ingredient concentration, stability, bioavailability, and sterility are non-negotiable. Deviation isn't a cost-of-doing-business variable; it's a regulatory and patient safety failure. The discipline of applying that standard to cosmetic manufacturing — an industry where regulatory requirements have historically been lighter than pharmaceuticals — is what makes Trilogy's products perform differently than those from manufacturers operating to less exacting standards.

This shows up in specific, measurable ways:

• Active ingredient concentration: Many cosmetic manufacturers include active ingredients at concentrations below their effective therapeutic range — technically present on the label, functionally absent in the product. Trilogy's pharmaceutical background means formulations are developed with appropriate active concentrations — the amounts that the research supports as effective.
• Stability: A product that performs in the lab must perform on the shelf. Stability testing at Trilogy confirms that formulations maintain their active ingredient concentrations and physical properties through the product's intended shelf life.
• Ingredient integrity: Raw material testing on intake ensures that what the supplier claims is in the ingredient is actually what's in the ingredient — at the stated concentration and without contaminants.

What MoCRA Compliance Means for Your Brand

The Modernization of Cosmetics Regulation Act, signed into law in 2022, significantly expanded FDA oversight of cosmetic products sold in the United States. Requirements now include:

• Facility registration: Cosmetic manufacturers must register with the FDA — a requirement that previously didn't exist.
• Product listing: All products marketed in the U.S. must be listed with the FDA, including ingredient details.
• Serious adverse event reporting: Manufacturers and brands must report serious adverse events associated with their products to the FDA.
• Substantiation of safety: Cosmetic products must have adequate substantiation of safety.

For brands selling through licensed professionals, retailers, or e-commerce, working with a MoCRA-compliant manufacturer isn't optional — it's a legal requirement and a liability management imperative. Trilogy's MoCRA-compliant operations mean every product manufactured at the facility is positioned for full regulatory compliance from the day it ships.

What Trilogy Offers Brands and Practices

Trilogy serves two primary manufacturing paths — both backed by the same GMP ISO 22716-certified facility:

• Private label: Access to Trilogy's library of 554-plus professionally developed formulations under your brand name, with customizable packaging and labeling. Minimum order quantities start at 25 units — making private label accessible for growing practices and emerging brands without requiring large upfront inventory commitments.
• Custom manufacturing: Work directly with Trilogy's team of chemists, pharmacist, licensed estheticians, and brand consultants to develop a proprietary formulation from concept through finished product. Custom development is available from small pilot runs through full-scale production at 100,000-plus units.

The team at Trilogy isn't a catalog and a checkout form. It's a multi-disciplinary group of human experts who engage with each brand's specific goals, client profile, and clinical environment — from the first conversation through delivery.

Start Your Skincare Line With Trilogy Laboratories

Trilogy Laboratories is located at 10060 Amberwood Road, Suite 8, in Fort Myers, Florida. To start a conversation about private label, custom manufacturing, or simply to understand what the Trilogy partnership looks like for your brand or practice, call (239) 939-5454 or visit trilogylaboratories.com. When your brand's name is on the label, the manufacturing standard behind it is your standard too. That's worth choosing carefully.